Trial
NCT02828124
A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Hepatocellular Carcinoma
Intervention
BMS-986183
Why stopped
Business objectives have changed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-30